A novel treatment for limited mouth opening due to facial fibrosis: A case series - 13/12/17
Doi : 10.1016/j.jaad.2017.07.006
Kara Hoverson, MD a, ⁎ 
, Tracy Love, MD b, Thomas K. Lam, MD a, Jason D. Marquart, MD a
, Tracy Love, MD b, Thomas K. Lam, MD a, Jason D. Marquart, MD a a Dermatology Service, Walter Reed National Military Medical Center, Bethesda, Maryland
b Dermatology Service, Kimbrough Ambulatory Care Center, Fort Meade, Maryland
∗Correspondence to: Kara Hoverson, MD, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889Walter Reed National Military Medical Center8901 Rockville PikeBethesdaMD20889
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
© 2017
Publié par Elsevier Masson SAS.
Vol 78 - N° 1
P. 190-192 - janvier 2018 Retour au numéro
Article précédent
- Nifedipine cream versus sildenafil cream for patients with secondary Raynaud phenomenon: A randomized, double-blind, controlled pilot study
- Ximena Wortsman, Pablo Del Barrio-Díaz, Rodrigo Meza-Romero, Christine Poehls-Risco, Cristián Vera-Kellet
- Botulinum toxin type A for the treatment of localized recalcitrant chronic pruritus
- Emily Boozalis, Mary Sheu, Jacqueline Selph, Shawn G. Kwatra
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?